Guidelines for the prevention of CMV transmisson by transfusion of blood components

Human cytomegalovirus can be transmitted by direct contact and iatrogenically by transfusion of blood components and by transplanted tissues or organs. After a primary, mostly asymptomatic infection, it remains latent in the body in CD34 + hematopoietic stem cells of the bone marrow and in periphera...

Full description

Saved in:
Bibliographic Details
Published in:Zdravniški vestnik (Ljubljana, Slovenia : 1992) Slovenia : 1992), 2013-06, Vol.82 (6)
Main Authors: Marko Cukjati, Vladan Rajić, Darja Paro Panjan, Irena Štucin Gantar, Mojca Grošelj Grenc, Urška Rahne Potokar, Samo Zver
Format: Article
Language:eng ; slv
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 6
container_start_page
container_title Zdravniški vestnik (Ljubljana, Slovenia : 1992)
container_volume 82
creator Marko Cukjati
Vladan Rajić
Darja Paro Panjan
Irena Štucin Gantar
Mojca Grošelj Grenc
Urška Rahne Potokar
Samo Zver
description Human cytomegalovirus can be transmitted by direct contact and iatrogenically by transfusion of blood components and by transplanted tissues or organs. After a primary, mostly asymptomatic infection, it remains latent in the body in CD34 + hematopoietic stem cells of the bone marrow and in peripheral blood monocytes. Symptomatic CMV infection or viral reactivation with involvement of different organs can develop in immunocompromised patients. Prevention of CMV transmission by transfusion of blood components is important in patients at increased risk: intrauterine and neonatal transfusions, pregnant women, children with immune deficiency, patients with hemopoietic progenitor stem cell and organ transplants. The most important approaches to the prevention of CMV transmission are a selection of safe donors, serological testing for CMV antibodies, leukodepletion, pathogen inactivation, and rational use of blood. None of these measures are 100 % efficient, but they can complement each other.
format article
fullrecord <record><control><sourceid>doaj</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c501650db46741da97072bbdbfd2ae35</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c501650db46741da97072bbdbfd2ae35</doaj_id><sourcerecordid>oai_doaj_org_article_c501650db46741da97072bbdbfd2ae35</sourcerecordid><originalsourceid>FETCH-LOGICAL-d151t-a7033da9cd376b1be7830d2beaf62e090be34a898f65025ae00de656cbca6e523</originalsourceid><addsrcrecordid>eNotTdtKwzAYLqLgnL5DXqDwJ2mS9lKKzsHECw-35U_zRzPaZiSdsLe3uF19B77DVbHiquYlCFFdL1zyugRZmdviLuc9gKq1aFbF--YYHA1hosx8TGz-IXZI9EvTHOLEomft6xebE055DDkvlj2dpT_mS8IOMTrWx_EQp6WX74sbj0Omhwuui8_np4_2pdy9bbbt4650XPG5RANSOmx6J4223JKpJThhCb0WBA1YkhXWTe21AqGQABxppXvboyYl5LrYnnddxH13SGHEdOoihu7fiOm7wzSHfqCuV8CXFWcrbSq-nBowwlpnvRNIUsk_lmFbVA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Guidelines for the prevention of CMV transmisson by transfusion of blood components</title><source>Publicly Available Content Database</source><creator>Marko Cukjati ; Vladan Rajić ; Darja Paro Panjan ; Irena Štucin Gantar ; Mojca Grošelj Grenc ; Urška Rahne Potokar ; Samo Zver</creator><creatorcontrib>Marko Cukjati ; Vladan Rajić ; Darja Paro Panjan ; Irena Štucin Gantar ; Mojca Grošelj Grenc ; Urška Rahne Potokar ; Samo Zver</creatorcontrib><description>Human cytomegalovirus can be transmitted by direct contact and iatrogenically by transfusion of blood components and by transplanted tissues or organs. After a primary, mostly asymptomatic infection, it remains latent in the body in CD34 + hematopoietic stem cells of the bone marrow and in peripheral blood monocytes. Symptomatic CMV infection or viral reactivation with involvement of different organs can develop in immunocompromised patients. Prevention of CMV transmission by transfusion of blood components is important in patients at increased risk: intrauterine and neonatal transfusions, pregnant women, children with immune deficiency, patients with hemopoietic progenitor stem cell and organ transplants. The most important approaches to the prevention of CMV transmission are a selection of safe donors, serological testing for CMV antibodies, leukodepletion, pathogen inactivation, and rational use of blood. None of these measures are 100 % efficient, but they can complement each other.</description><identifier>ISSN: 1318-0347</identifier><identifier>EISSN: 1581-0224</identifier><language>eng ; slv</language><publisher>Slovenian Medical Association</publisher><ispartof>Zdravniški vestnik (Ljubljana, Slovenia : 1992), 2013-06, Vol.82 (6)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Marko Cukjati</creatorcontrib><creatorcontrib>Vladan Rajić</creatorcontrib><creatorcontrib>Darja Paro Panjan</creatorcontrib><creatorcontrib>Irena Štucin Gantar</creatorcontrib><creatorcontrib>Mojca Grošelj Grenc</creatorcontrib><creatorcontrib>Urška Rahne Potokar</creatorcontrib><creatorcontrib>Samo Zver</creatorcontrib><title>Guidelines for the prevention of CMV transmisson by transfusion of blood components</title><title>Zdravniški vestnik (Ljubljana, Slovenia : 1992)</title><description>Human cytomegalovirus can be transmitted by direct contact and iatrogenically by transfusion of blood components and by transplanted tissues or organs. After a primary, mostly asymptomatic infection, it remains latent in the body in CD34 + hematopoietic stem cells of the bone marrow and in peripheral blood monocytes. Symptomatic CMV infection or viral reactivation with involvement of different organs can develop in immunocompromised patients. Prevention of CMV transmission by transfusion of blood components is important in patients at increased risk: intrauterine and neonatal transfusions, pregnant women, children with immune deficiency, patients with hemopoietic progenitor stem cell and organ transplants. The most important approaches to the prevention of CMV transmission are a selection of safe donors, serological testing for CMV antibodies, leukodepletion, pathogen inactivation, and rational use of blood. None of these measures are 100 % efficient, but they can complement each other.</description><issn>1318-0347</issn><issn>1581-0224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNotTdtKwzAYLqLgnL5DXqDwJ2mS9lKKzsHECw-35U_zRzPaZiSdsLe3uF19B77DVbHiquYlCFFdL1zyugRZmdviLuc9gKq1aFbF--YYHA1hosx8TGz-IXZI9EvTHOLEomft6xebE055DDkvlj2dpT_mS8IOMTrWx_EQp6WX74sbj0Omhwuui8_np4_2pdy9bbbt4650XPG5RANSOmx6J4223JKpJThhCb0WBA1YkhXWTe21AqGQABxppXvboyYl5LrYnnddxH13SGHEdOoihu7fiOm7wzSHfqCuV8CXFWcrbSq-nBowwlpnvRNIUsk_lmFbVA</recordid><startdate>20130601</startdate><enddate>20130601</enddate><creator>Marko Cukjati</creator><creator>Vladan Rajić</creator><creator>Darja Paro Panjan</creator><creator>Irena Štucin Gantar</creator><creator>Mojca Grošelj Grenc</creator><creator>Urška Rahne Potokar</creator><creator>Samo Zver</creator><general>Slovenian Medical Association</general><scope>DOA</scope></search><sort><creationdate>20130601</creationdate><title>Guidelines for the prevention of CMV transmisson by transfusion of blood components</title><author>Marko Cukjati ; Vladan Rajić ; Darja Paro Panjan ; Irena Štucin Gantar ; Mojca Grošelj Grenc ; Urška Rahne Potokar ; Samo Zver</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d151t-a7033da9cd376b1be7830d2beaf62e090be34a898f65025ae00de656cbca6e523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; slv</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marko Cukjati</creatorcontrib><creatorcontrib>Vladan Rajić</creatorcontrib><creatorcontrib>Darja Paro Panjan</creatorcontrib><creatorcontrib>Irena Štucin Gantar</creatorcontrib><creatorcontrib>Mojca Grošelj Grenc</creatorcontrib><creatorcontrib>Urška Rahne Potokar</creatorcontrib><creatorcontrib>Samo Zver</creatorcontrib><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Zdravniški vestnik (Ljubljana, Slovenia : 1992)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marko Cukjati</au><au>Vladan Rajić</au><au>Darja Paro Panjan</au><au>Irena Štucin Gantar</au><au>Mojca Grošelj Grenc</au><au>Urška Rahne Potokar</au><au>Samo Zver</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Guidelines for the prevention of CMV transmisson by transfusion of blood components</atitle><jtitle>Zdravniški vestnik (Ljubljana, Slovenia : 1992)</jtitle><date>2013-06-01</date><risdate>2013</risdate><volume>82</volume><issue>6</issue><issn>1318-0347</issn><eissn>1581-0224</eissn><abstract>Human cytomegalovirus can be transmitted by direct contact and iatrogenically by transfusion of blood components and by transplanted tissues or organs. After a primary, mostly asymptomatic infection, it remains latent in the body in CD34 + hematopoietic stem cells of the bone marrow and in peripheral blood monocytes. Symptomatic CMV infection or viral reactivation with involvement of different organs can develop in immunocompromised patients. Prevention of CMV transmission by transfusion of blood components is important in patients at increased risk: intrauterine and neonatal transfusions, pregnant women, children with immune deficiency, patients with hemopoietic progenitor stem cell and organ transplants. The most important approaches to the prevention of CMV transmission are a selection of safe donors, serological testing for CMV antibodies, leukodepletion, pathogen inactivation, and rational use of blood. None of these measures are 100 % efficient, but they can complement each other.</abstract><pub>Slovenian Medical Association</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1318-0347
ispartof Zdravniški vestnik (Ljubljana, Slovenia : 1992), 2013-06, Vol.82 (6)
issn 1318-0347
1581-0224
language eng ; slv
recordid cdi_doaj_primary_oai_doaj_org_article_c501650db46741da97072bbdbfd2ae35
source Publicly Available Content Database
title Guidelines for the prevention of CMV transmisson by transfusion of blood components
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A01%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Guidelines%20for%20the%20prevention%20of%20CMV%20transmisson%20by%20transfusion%20of%20blood%20components&rft.jtitle=Zdravnis%CC%8Cki%20vestnik%20(Ljubljana,%20Slovenia%20:%201992)&rft.au=Marko%20Cukjati&rft.date=2013-06-01&rft.volume=82&rft.issue=6&rft.issn=1318-0347&rft.eissn=1581-0224&rft_id=info:doi/&rft_dat=%3Cdoaj%3Eoai_doaj_org_article_c501650db46741da97072bbdbfd2ae35%3C/doaj%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-d151t-a7033da9cd376b1be7830d2beaf62e090be34a898f65025ae00de656cbca6e523%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true